DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,034 filers reported holding DANAHER CORPORATION in Q1 2023. The put-call ratio across all filers is 0.99 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $987,182,070 | +0.4% | 3,978,968 | -2.9% | 0.56% | +2.9% |
| Q2 2023 | $983,204,840 | -3.3% | 4,096,686 | +1.5% | 0.54% | -12.0% |
| Q1 2023 | $1,016,874,525 | +95880.4% | 4,034,184 | +1.1% | 0.62% | -13.7% |
| Q4 2022 | $1,059,461 | -99.9% | 3,991,639 | +1.3% | 0.72% | -6.2% |
| Q3 2022 | $1,017,624,000 | +4.6% | 3,939,849 | +2.6% | 0.76% | +10.7% |
| Q2 2022 | $973,272,000 | -11.4% | 3,839,035 | +2.5% | 0.69% | +6.3% |
| Q1 2022 | $1,098,558,000 | -7.6% | 3,745,126 | +3.7% | 0.65% | -2.7% |
| Q4 2021 | $1,188,523,000 | +13.3% | 3,612,423 | +4.8% | 0.67% | +2.1% |
| Q3 2021 | $1,049,170,000 | +17.6% | 3,446,230 | +3.7% | 0.65% | +16.4% |
| Q2 2021 | $892,246,000 | +23.5% | 3,324,810 | +3.6% | 0.56% | +10.0% |
| Q1 2021 | $722,626,000 | +5.2% | 3,210,528 | +3.8% | 0.51% | -1.2% |
| Q4 2020 | $686,849,000 | +9.1% | 3,091,966 | +5.7% | 0.52% | -6.5% |
| Q3 2020 | $629,622,000 | +27.1% | 2,923,988 | +4.4% | 0.55% | +14.1% |
| Q2 2020 | $495,361,000 | +90.5% | 2,801,341 | +49.1% | 0.48% | +50.0% |
| Q1 2020 | $259,988,000 | +34657.8% | 1,878,392 | +38462.8% | 0.32% | +32100.0% |
| Q4 2019 | $748,000 | +8.2% | 4,871 | +1.8% | 0.00% | 0.0% |
| Q3 2019 | $691,000 | +9.9% | 4,783 | +8.6% | 0.00% | 0.0% |
| Q2 2019 | $629,000 | -38.6% | 4,403 | -49.3% | 0.00% | 0.0% |
| Q1 2019 | $1,025,000 | +135.1% | 8,685 | +105.6% | 0.00% | 0.0% |
| Q4 2018 | $436,000 | -17.0% | 4,225 | -12.6% | 0.00% | 0.0% |
| Q3 2018 | $525,000 | +1.2% | 4,834 | -8.1% | 0.00% | 0.0% |
| Q2 2018 | $519,000 | -8.1% | 5,262 | -8.8% | 0.00% | 0.0% |
| Q1 2018 | $565,000 | +9.5% | 5,768 | +3.7% | 0.00% | 0.0% |
| Q4 2017 | $516,000 | +17.0% | 5,560 | +8.1% | 0.00% | 0.0% |
| Q3 2017 | $441,000 | -3.7% | 5,145 | -5.1% | 0.00% | 0.0% |
| Q2 2017 | $458,000 | +2.5% | 5,423 | +3.8% | 0.00% | 0.0% |
| Q1 2017 | $447,000 | +12.0% | 5,224 | +1.9% | 0.00% | 0.0% |
| Q4 2016 | $399,000 | -11.7% | 5,127 | -11.0% | 0.00% | 0.0% |
| Q3 2016 | $452,000 | -0.9% | 5,760 | +1.1% | 0.00% | 0.0% |
| Q2 2016 | $456,000 | -12.0% | 5,697 | +3.5% | 0.00% | 0.0% |
| Q1 2016 | $518,000 | +5.7% | 5,505 | +4.3% | 0.00% | 0.0% |
| Q4 2015 | $490,000 | +53.1% | 5,279 | +41.5% | 0.00% | 0.0% |
| Q4 2014 | $320,000 | – | 3,730 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |